ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MOLN vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Molecular Partners AG (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: MOLN 0 — MRK 3
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MOLN VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MOLN MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 74.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 20.70% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield — 3.42% — TIE /fcf-yield <GO>
Operating Margin — 34.30% — TIE /operating-margins <GO>
Net Profit Margin — 28.10% — TIE /net-margins <GO>
Revenue Growth (YoY) — 1.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.19 — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 7/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 41.5 51.7 -10.24 MRK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $132.4M $361.02B -$360.89B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MOLN REV MRK REV MOLN GROSS % MRK GROSS % MOLN FCF MRK FCF
FY 2025 — $65.01B — 74.8% — $12.36B
FY 2024 — $64.17B — 76.3% — $18.10B
FY 2023 — $60.12B — — — $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MOLN // BETA —
MRK // BETA 0.92